Siemens Healthcare Takes Top Honors in Both Market Shares and Technology, Making it Frost & Sullivan's Company of the Year in Interventional Radiology

MOUNTAIN VIEW, Calif., Aug. 21, 2013 /PRNewswire/ -- Based on its recent analysis of the interventional radiology market, Frost & Sullivan recognizes Siemens Healthcare with the 2013 North American Frost & Sullivan Award for Company of the Year. Siemens's technology and product innovation-centered growth strategy has helped it maintain its lead and momentum in market expansion, even during the recent industry-wide slowdown. Its smart innovations — backed by the value they generate at various levels of the care continuum, including clinical care, business enterprise as well as patients — have not only enhanced the standard of care but also offered myriad clinical and operational benefits.

While selling to the premium product tier is no surprise where a top-rung participant like Siemens Healthcare is concerned, the company also is demonstrating a keen interest in the mid-to-low market tiers. Its flexible configurations are tailored to each customer's needs, generating significant value in every market segment.

"In addition to competing effectively at both ends of the market, Siemens Healthcare can also pride itself in creating entirely new product tiers," said Frost & Sullivan Industry Principal Nadim Daher. "Siemens has been at the forefront of the early development of hybrid interventional imaging solutions over the last 10 years, with Artis zeego being the first such solution to enter the market in 2007—more than two years ahead of the competition."

Much as it widened the scope of interventional imaging in modern-day clinical practice, Siemens Healthcare forged ahead in the sphere of three-dimensional (3D) visualization in the interventional lab with its syngo DynaCT. Remarkably, the company has been able to maintain that edge nearly 10 years later. Siemens's latest product launches have enhanced all the major product elements of image quality, acquisition speed, and the dose and contrast efficiency in 3D imaging.

The Artis Q product line — Siemens Healthcare's new line of premium angiography systems — embodies enhancements such as syngo DynaCT Micro in addition to numerous other innovations such as Q.zen. In the Q.zen configuration, advances include a newly designed digital crystalline silicon detector that allows better detail visualization at lower radiation dosages. These new systems incorporate Siemens' second generation of proprietary X-ray tube flat emitter technology, which also contributes to higher dose efficiency of these systems.

Siemens Healthcare can be deemed the first vendor to bring functional imaging to a clinical setting during interventional procedures. Similar to its hybrid interventional imaging solution, Siemens' parenchymal blood volume (PBV) technology, syngo DynaPBV, is another industry first. Following its release in 2009 as a breakthrough neurology application for brain imaging (syngo DynaPBV Neuro), syngo DynaPBV Body applies 3D functional imaging to a whole new set of interventional radiology procedures.

The highly sophisticated algorithms that constitute the CARE (Combined Applications to Reduce Exposure) and CLEAR software packages represent another layer of product differentiation for Siemens. The CARE portfolio builds on the legacy of cutting-edge dose reduction, monitoring, and reporting techniques and is delivered to customers as standard — not at added cost — in all of Siemens' Artis zee, zeego, Q, and Q.zen systems.

"As an established interventional radiology vendor of choice in the largest number of university and academic hospitals in the U.S., Siemens Healthcare is best suited to address the needs of newly consolidated hospital networks," noted Daher. "It is also strategically placed to help in the creation of clinical specialty centers of excellence in cardiology, trauma and oncology."

Each year, Frost & Sullivan presents this award to the company that has demonstrated excellence in terms of growth strategy and implementation. The award recognizes a high degree of innovation with products and technologies, and the resulting leadership in terms of customer value and market penetration.

Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research to identify best practices in the industry.

About Siemens Healthcare

The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens offers its customers products and solutions for the entire range of patient care from a single source - from prevention and early detection to diagnosis, and on to treatment and aftercare.

By optimizing clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 51,000 employees worldwide and operates around the world. In fiscal year 2012 (to September 30), the Sector posted revenue of 13.6 billion euros and profit of 1.8 billion euros. For further information please visit: http://www.siemens.com/healthcare.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

• The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
• The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:     Start the discussion

Join Us:           Join our community

Subscribe:       Newsletter on "the next big thing"

Register:        Gain access to visionary innovation

Contact:

Mireya Espinoza
P: 210. 247.3870
F: 210.348.1003
E: [email protected]

SOURCE Frost & Sullivan